Reduction seen in rate of change in modifiable cardiovascular risk, but most changes in individual modifiable risk factors were not significant
Decreased risk for psychosis seen in those receiving rehabilitation treatment for amphetamine misuse during deferred prosecution
63.0 percent of patients reached full remission at day three; remission remained high at 69.5 percent at week six
Struggles include finding the right medication and medication side effects
In general, change was inconsistent and sometimes regressive -- for example, for dangerousness for schizophrenia
Findings seen for COVID-19 infection, hospitalization, and mortality
Prevalence estimates of type 2 diabetes 40 percent for those with sleep disorder, 21 percent for binge eating disorder
Patients with schizophrenia, mood disorders, anxiety disorders have increased odds of COVID-19 mortality
Large effect sizes seen for Beck Depression Inventory, Recovery Assessment Scale, Rosenberg Self-Esteem Scale
However, risk for incident psychiatric morbidity was similar for those with negative SARS-CoV-2 test result and was higher with influenza